1 Cannabis Stock That Could Be in Danger of Running Out of Money

The Green Organic Dutchman Holdings (TSX:TGOD) is a stock cannabis investors should stay far away from.

Pot stocks are doing a bit better this year than in 2019, but that, unfortunately, isn’t saying much. It also doesn’t mean that investing in cannabis is any safer than it was several months ago. There’s arguably even more risk in the industry now that a recession all but a formality. People will have less money to spend on discretionary expenses like marijuana. And without strong revenue growth this year, there could be a lot more red and cash burn for many cannabis companies. For some, they could run out of cash entirely.

One stock that cannabis investors should keep a close eye on is The Green Organic Dutchman Holdings (TSX:TGOD). The pot producer released its first-quarter results last month, and they weren’t all that encouraging.

TGOD’s struggles continue

In Q1, TGOD generated $3.1 million in revenue — which is less than the $3.3 million that it reported in the fourth quarter. The company also reported a loss of $73.4 million, as it incurred multiple impairment charges that weighed down its financials. But with a $15.3 million loss already at the operational level, the pot stock was going to report a loss with or without the impairments.

TGOD’s incurred an operating loss of $15 million or more in each of its past six quarterly results.

A more concerning issue for TGOD investors, however, is the company’s rate of cash burn. In Q1, the pot producer used $13.1 million to fund its operating activities. While that’s down from the $22.5 million TGOD burned a year ago, it’s still a dangerously high amount given that its cash and cash equivalents on March 31 totaled just $4.8 million. During the quarter, TGOD raised $6.7 million in cash from issuing debt. And its bills are only continuing to pile up.

Its current assets as of the end of March were just $32.5 million — less than the $39.3 million that it had in accounts payable and accrued liabilities. Those are bills that the company’s going need to pay in the near future. Its loans total $22.9 million, which is 36% higher than the $16.9 million that TGOD reported a year ago. It’s not a good sign when your debts are growing at a higher rate than your sales (Q1’s sales were up 27% compared to the same quarter last year).

With lots of cash burn and mounting debt and bills to be paid, it’s going to be a tough road ahead for TGOD.

Bottom line

For a stock that’s down around 90% in 12 months, it’s no surprise why TGOD is where it is today given its low sales and consistent losses.

While the company may still be able to raise money, that’s only going to get more challenging to do as its share price continues to fall. With many other pot stocks to choose from, investors are better off investing in companies that have more cash and stronger sales numbers.

TGOD is a high-risk buy in an already risky industry. There’s just no reason to get excited about the stock given its track record and the challenges that lay ahead for the company. And there’s a real danger that it’ll run out of money and become the industry’s latest casualty.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned. 

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »